Harlan S Robins, Chief Scientific Officer, on July 02, 2026, sold 386,240 shares in Adaptive Biotechnologies (ADPT) for $8,501,149. Following the Form 4 filing with the SEC, Robins has control over a total of 1,019,658 common shares of the company, with 1,019,658 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1478320/000178085126000015/xslF345X05/form4.xml
Robert Lechleider, Chief Medical Officer, on July 02, 2026, sold 55,000 shares in Immunome (IMNM) for $1,244,331. Following the Form 4 filing with the SEC, Lechleider has control over a total of 15,805 common shares of the company, with 15,805 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/xslF345X05/form4-07072026_090711.xml
Charles Collier, President, Roku Media, on July 06, 2026, sold 20,538 shares in Roku (ROKU) for $2,926,798. Following the Form 4 filing with the SEC, Collier has control over a total of 15,200 Class A common shares of the company, with 15,200 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1428439/000195166526000018/xslF345X05/form4.xml
Richard T Hume, Director, on July 06, 2026, sold 5,000 shares in TD Synnex (SNX) for $1,214,858. Following the Form 4 filing with the SEC, Hume has control over a total of 18,537 common shares of the company, with 18,537 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1177394/000117739426000078/xslF345X05/wk-form4_1783459126.xml